2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow Castleman Disease: new trials by email Literature Review of Castleman Disease trials Research Report on Castleman Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman's Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment tocilizumab [RoActemra/Actemra] - Castleman's Disease | Phase 1 | Completed | Hoffmann-La Roche | 3 | 2006-08-01 | 2016-11-02 |
| A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease CNTO 328 - Lymphoma, Non-Hodgkin, Multiple Myeloma | Phase 1 | Completed | Centocor, Inc. | 67 | 2005-05-01 | 2014-07-01 |
Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Blood Protein Disorders (1) · Cardiovascular Diseases (1) · Hematologic Diseases (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1) · Lymphoma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Plasma Cell (1) · Paraproteinemias (1)
siltuximab (1) · tocilizumab (1)
Centocor, Inc. (1) · Hoffmann-La Roche (1)
United States (2)